Stocks and Investing Stocks and Investing
Fri, March 27, 2020

David Lewis Maintained (ZBH) at Buy with Decreased Target to $140 on, Mar 27th, 2020


Published on 2024-10-27 01:13:26 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Decreased Target from $175 to $140 on, Mar 27th, 2020.

David has made no other calls on ZBH in the last 4 months.



There are 10 other peers that have a rating on ZBH. Out of the 10 peers that are also analyzing ZBH, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Pito Chickering of "Deutsche Bank" Maintained at Hold with Increased Target to $160 on, Wednesday, February 5th, 2020


These are the ratings of the 9 analyists that currently disagree with David


  • Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $93 on, Tuesday, March 24th, 2020
  • Joanna Wiensch of "Citigroup" Initiated at Strong Buy and Held Target at $168 on, Thursday, March 5th, 2020
  • Amit Hazan of "Goldman Sachs" Initiated at Strong Buy and Held Target at $177 on, Thursday, February 13th, 2020
  • Jeff Johnson of "Baird" Maintained at Buy with Increased Target to $172 on, Wednesday, February 5th, 2020
  • Lawrence Keusch of "Raymond James" Maintained at Strong Buy with Increased Target to $190 on, Wednesday, February 5th, 2020
  • Mike Matson of "Needham" Reiterated at Strong Buy with Increased Target to $189 on, Tuesday, February 4th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $170 on, Friday, January 10th, 2020
  • Kaila Krum of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $179 on, Wednesday, January 8th, 2020
  • Matthew O'Brien of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $170 on, Tuesday, January 7th, 2020
Contributing Sources